Intuitive Surgical Inc

Latest Results (20.10.2025):

Intuitive Surgical Inc reported robust financial results for the second quarter of 2025, showcasing substantial growth in both revenue and net income compared to the same period in 2024. The company continued to expand its global presence and enhance its da Vinci surgical systems portfolio.

Revenue Growth

Second quarter 2025 revenue increased by 21% to $2.44 billion, up from $2.01 billion in Q2 2024. This growth was driven by a surge in instruments and accessories revenue, which rose by 18% to $1.47 billion.

Net Income Improvement

GAAP net income attributable to Intuitive Surgical Inc reached $658 million, or $1.81 per diluted share, compared to $527 million, or $1.46 per diluted share, in the second quarter of 2024. Non-GAAP net income also saw a significant rise to $798 million, or $2.19 per diluted share, from $641 million, or $1.78 per diluted share.

System Installations and Installed Base

The company placed 395 da Vinci surgical systems in Q2 2025, up from 341 in Q2 2024. This includes 180 new da Vinci 5 systems, compared to 70 in the previous year. The installed base grew to 10,488 systems as of June 30, 2025, reflecting a 14% increase from 9,203 systems on June 30, 2024.

Global Certification and Regulatory Milestones

In July 2025, Intuitive Surgical obtained European certification for its da Vinci 5 surgical system, expanding its use in minimally invasive procedures. Additionally, in June 2025, the company secured regulatory clearance in Japan for the da Vinci 5 system across all surgical specialties except cardiac procedures.

Financial Outlook for 2025

Intuitive Surgical forecasts worldwide da Vinci procedure growth of approximately 15.5% to 17% in 2025. The company anticipates a non-GAAP gross profit margin between 66% and 67% of revenue and expects non-GAAP operating expenses to grow by 10% to 14% during the year.